Peter S. Jensen, MD
	
					
					
	
	The REACH Institute
	
	485 Seventh Avenue
	Suite 1510
	New York, 
	NY
	USA
	10017
	
	Papers:
	1 
	The Dramatic Rise in Neuroleptic Use in Children: Why Do We Do It, What Does It Buy Us, and What Does It Cost Us? 
	
	19 
	Real-World Applications of New ADHD Clinical Trials 
	
	24 
	A Child Psychiatrist for Our Time: The Life and Work of David Mrazek, M.D. 
	
	1.29 
	Strategies for Improved Classification of Pediatric Biobank Participants 
	
	3.2 
	Clinical Correlates of Ferritin Level and ADHD in Children: Should We Check Ferritin Level? 
	
	37 
	Innovative Systemic Interventions in Child Welfare and Foster Care 
	
	4.30 
	Poster Docent Selection: Pediatricians and Primary Care Physician's Knowledge, Comfort, and Practices About Children's Mental Health Before and After a Theory-Based Training 
	
	4.56 
	Does Child Behavior Checklist Juvenile Bipolar Profile Predict Bipolar Diagnoses and Symptoms in Children with ADHD? A 14-Year Longitudinal Follow-Up 
	
	4.57 
	Risk for Emerging Bipolar Disorder, Bipolar Variants, and Symptoms in Children with ADHD, Now Grown Up 
	
	6.33 
	Poster Docent Selection: The Evolution of Child and Adolescent Psychiatry Primary Care: New York's State-University Collaborative Consultation Program for Primary Care 
	
	11.4 
	Lessons Learned in Seven Years' Task Shifting Efforts in Primary Care Settings, United States and Abroad 
	
